MX352647B - Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. - Google Patents

Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.

Info

Publication number
MX352647B
MX352647B MX2014000593A MX2014000593A MX352647B MX 352647 B MX352647 B MX 352647B MX 2014000593 A MX2014000593 A MX 2014000593A MX 2014000593 A MX2014000593 A MX 2014000593A MX 352647 B MX352647 B MX 352647B
Authority
MX
Mexico
Prior art keywords
colonoscopy
composition
timing
picosulate
administered
Prior art date
Application number
MX2014000593A
Other languages
English (en)
Other versions
MX2014000593A (es
Inventor
Raymond E Joseph
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46642617&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX352647(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2014000593A publication Critical patent/MX2014000593A/es
Publication of MX352647B publication Critical patent/MX352647B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Con base en la presente descripción, un intervalo de tiempo mínimo se puede lograr entre la última ingestión de una composición de picosulfato y la realización de la colonoscopía. Por ejemplo, la presente descripción se dirige a un método para temporizar un procedimiento de colonoscopía realizado en un paciente necesitado del mismo, que comprende: administrar, al paciente, un equipo de composición intestinal de picosulfato de acuerdo con las instrucciones del equipo; realizar el procedimiento menos de aproximadamente 4 horas después de la administración del equipo.
MX2014000593A 2011-07-15 2012-07-16 Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato. MX352647B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161508189P 2011-07-15 2011-07-15
PCT/US2012/046874 WO2013012783A1 (en) 2011-07-15 2012-07-16 Method for timing a colonoscopy wherein a picosulate composition is administered

Publications (2)

Publication Number Publication Date
MX2014000593A MX2014000593A (es) 2014-07-30
MX352647B true MX352647B (es) 2017-12-04

Family

ID=46642617

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000593A MX352647B (es) 2011-07-15 2012-07-16 Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.

Country Status (15)

Country Link
US (1) US9669110B2 (es)
EP (2) EP3269368A1 (es)
JP (2) JP6376975B2 (es)
KR (1) KR20140063602A (es)
CN (1) CN103841970A (es)
AU (1) AU2012284200B2 (es)
BR (1) BR112014000843A8 (es)
CA (1) CA2841751A1 (es)
DK (1) DK2731607T3 (es)
ES (1) ES2655172T3 (es)
HU (1) HUE034895T2 (es)
MX (1) MX352647B (es)
NO (1) NO2731607T3 (es)
PL (1) PL2731607T3 (es)
WO (1) WO2013012783A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117057D0 (en) * 2001-07-12 2001-09-05 Ferring Bv Pharmaceutical composition
TWI442932B (zh) 2008-02-11 2014-07-01 Ferring Int Ct Sa 以ＧｎＲＨ拮抗劑治療攝護腺癌的方法
NZ595767A (en) * 2009-05-01 2012-12-21 Ferring Bv Composition for the treatment of prostate cancer
US20110039787A1 (en) * 2009-07-06 2011-02-17 Ferring International Center S.A. Compositions, kits and methods for treating benign prostate hyperplasia
ES2617336T3 (es) 2010-10-27 2017-06-16 Ferring B.V. Procedimiento para la fabricación de degarelix y sus productos intermedios
EP2447276A1 (en) 2010-10-27 2012-05-02 Ferring B.V. Process for the manufacture of Degarelix and its intermediates
JO3755B1 (ar) 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
AR092840A1 (es) 2012-06-01 2015-05-06 Ferring Bv Elaboracion de degarelix
CN103405395B (zh) * 2013-08-23 2015-04-22 山东省医药工业研究所 匹可硫酸钠肠溶片及其制备方法
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) * 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
CN105456264B (zh) * 2015-12-03 2018-07-10 广州瑞尔医药科技有限公司 双效缓泻的药物组合物及其制备方法
GB2559405A (en) * 2017-02-06 2018-08-08 Owlstone Med Ltd Improvements in or relating to preparation of subjects for medical or veterinary examination

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2300006A4 (en) * 2008-05-23 2011-11-30 Kingston General Hospital COLON CLEANING METHOD AND KIT
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations

Also Published As

Publication number Publication date
BR112014000843A8 (pt) 2017-10-10
EP2731607A1 (en) 2014-05-21
EP3269368A1 (en) 2018-01-17
BR112014000843A2 (pt) 2017-08-22
HUE034895T2 (hu) 2018-03-28
JP6376975B2 (ja) 2018-08-22
AU2012284200A1 (en) 2014-02-06
US20130018223A1 (en) 2013-01-17
CN103841970A (zh) 2014-06-04
US9669110B2 (en) 2017-06-06
KR20140063602A (ko) 2014-05-27
PL2731607T3 (pl) 2018-03-30
JP2017061560A (ja) 2017-03-30
DK2731607T3 (en) 2018-01-02
ES2655172T3 (es) 2018-02-19
WO2013012783A1 (en) 2013-01-24
CA2841751A1 (en) 2013-01-24
JP2014520884A (ja) 2014-08-25
EP2731607B1 (en) 2017-10-11
MX2014000593A (es) 2014-07-30
AU2012284200B2 (en) 2016-09-22
NO2731607T3 (es) 2018-03-10

Similar Documents

Publication Publication Date Title
MX352647B (es) Metodo para temporizar una colonoscopia en donde se administra una composicion de picosulfato.
PH12015501678A1 (en) Inhibitors of influenza viruses replication
IN2014MN01755A (es)
PH12014501133A1 (en) Compositions and methods for treating hepatitis c virus
IN2014KN00996A (es)
IN2014CN00562A (es)
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
MX2013006846A (es) Inhibidores de la replicacion de los virus de la influenza.
EA031157B9 (ru) Вводимая перорально кортикостероидная композиция
NZ619076A (en) Isoxazolines as inhibitors of fatty acid amide hydrolase
MX336187B (es) Metodo para tratar el mal de parkinson.
MY173215A (en) Acetylcysteine compositions and methods of use thereof
SG179027A1 (en) Dosage regimen for administering an epcamxcd3 bispecific antibody
MX336347B (es) Metodo para atenuar los efectos adversos del farmaco usando los acidos grasos omega-3 como un vehiculo terapeutico parenteral del farmaco.
NZ734152A (en) Compounds, compositions and methods useful for cholesterol mobilisation
MX2011009709A (es) Compuestos para el tratamiento de la inflamacion y del dolor.
WO2013028818A8 (en) Pyrimido- pyridazinone compounds and use thereof
WO2009155070A3 (en) Compositions and methods for treatment of inflammation and hyperkeratotic lesions
MX337593B (es) Gemcabeno y derivados para tratar la pancreatitis.
RU2011108787A (ru) Способ лечения больных красным плоским лишаем слизистой полости рта
MD520Z (ro) Metodă de tratament postoperator al pacienţilor cu litiază renală
UA64808U (ru) Способ фармакокорекции синдрома эндогенной интоксикации, возникающего в постдекомпрессионном периоде краш-синдрома
UA58749U (ru) Способ лечения стеатоза печени у больных туберкулезом
UA58754U (ru) Способ медицинской реабилитации больных неалкогольным стеатогепатитом на фоне сахарного диабета 2-го типа
UA69269U (ru) Способ лечения дисбактериоза у больных герпетическим стоматитом

Legal Events

Date Code Title Description
FG Grant or registration